Literature DB >> 6970033

Intraocular management of endophthalmitis. A systematic approach.

J G Diamond.   

Abstract

Antibiotics were administered intravitreally to 26 patients with culture-verified endophthalmitis. Vitrectomy surgery was combined with intravitreal antibiotic therapy in 14 of the cases. Pretreatment selection into a vitrectomy or nonvitrectomy group was determined by the duration of the disease, type of predisposing injury, and echographic findings. This diagnostic-treatment grouping allowed management to be initiated on the basis of the existing and potential virulence of the infecting process. The less virulent and often successfully managed Staphylococcus epidermidis accounted for 67% of cases in the nonvitrectomy group and only 14% in the vitrectomized series. During a mean follow-up period of 32 months (range, one to five years), retinal changes were monitored by visual acuity determination, electroretinography, and fluorescein angiography. An overall visual improvement (greater than or equal to 20/400) was found in 73% of the eyes treated. The causes for failure in the remaining cases may be related to retinal damage from the initiating trauma, organism response, and intraocular antibiotic therapy.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6970033     DOI: 10.1001/archopht.1981.03930010098011

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  22 in total

1.  Vitreous replacement by gas as a therapeutic modality in bacterial endophthalmitis.

Authors:  A M Mansour; E Ferguson; H Lucia; M Rajashekhar; H Li; T Margo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

Review 2.  Bacillus-induced endophthalmitis: new series of 10 cases and review of the literature.

Authors:  R Hemady; M Zaltas; B Paton; C S Foster; A S Baker
Journal:  Br J Ophthalmol       Date:  1990-01       Impact factor: 4.638

3.  Fleroxacin pharmacokinetics in aqueous and vitreous humors determined by using complete concentration-time data from individual rabbits.

Authors:  M H Miller; A Madu; G Samathanam; D Rush; C N Madu; K Mathisson; M Mayers
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

4.  Prognostic factors associated with the visual outcome after vitrectomy for endophthalmitis.

Authors:  K U Bartz-Schmidt; J Bermig; B Kirchhof; P Wiedemann; P Walter; K Heimann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

5.  Ocular toxicity of multiple intravitreal DHPG injections.

Authors:  M O Yoshizumi; D Lee; V Vinci; S Fajardo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

Review 6.  Antibiotic therapy for ocular infection.

Authors:  R W Snyder; D B Glasser
Journal:  West J Med       Date:  1994-12

Review 7.  Bacillus cereus endophthalmitis.

Authors:  D B David; G R Kirkby; B A Noble
Journal:  Br J Ophthalmol       Date:  1994-07       Impact factor: 4.638

Review 8.  Infectious endophthalmitis after cataract surgery.

Authors:  D S Hughes; R J Hill
Journal:  Br J Ophthalmol       Date:  1994-03       Impact factor: 4.638

9.  Intravitreal human immune globulin in a rabbit model of Staphylococcus aureus toxin-mediated endophthalmitis: a potential adjunct in the treatment of endophthalmitis.

Authors:  Dennis P Han
Journal:  Trans Am Ophthalmol Soc       Date:  2004

10.  Antimicrobial pharmacokinetics in endophthalmitis treatment: studies of ceftazidime.

Authors:  T A Meredith
Journal:  Trans Am Ophthalmol Soc       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.